Are you passionate about medical writing and ensuring regulatory compliance in the medical device industry? Do you want to play a key role in creating clinical documentation that supports patient safety and innovation?
As part of our Clinical Affairs team, you will contribute to the development and maintenance of clinical evaluations and Post‑Market Clinical Follow‑up (PMCF) documentation for our hearing solutions portfolio. You will work closely with internal stakeholders and external authorities to ensure compliance with EU MDR and other regulatory requirements.
As a Medical Writer, you’ll combine scientific expertise with regulatory knowledge – delivering high‑quality clinical documentation and acting as a trusted advisor within the organization.
If you have any questions, contact the recruiter: Jakub ( jkby@demant.com)
Furthermore we would like to inform you that the company has an internal reporting procedure, which is available at: demantcompliance - Make a report (codeofconduct.app)
If the page does not load correctly, please refresh it using the Ctrl+F5 key combination
#LI-HYBRID #LI-JW1 #Demant_Poland

Demant is a world-leading hearing healthcare group built on a heritage of care, health and innovation since 1904. The Group offers solutions and services to help people connect and communicate with the world around them. For more than a century, the Demant Group has played a vital part in developing innovative technologies and gathering know-how to help improve people’s hearing and health. In every aspect, from providing hearing care to delivering hearing aids and diagnostic equipment and services to hearing care professionals and users all over the world, Demant is active and engaged.
The Demant Group operates in a global market with subsidiaries in more than 30 countries, employs more than 22,000 employees and generates annual revenue of more than DKK 22 billion. Our products are sold in more than 130 countries where we create life-changing differences through hearing health.
Listed on Nasdaq Copenhagen stock exchange as a blue chip stock, Demant is the parent company behind world-renowned and commercially successful brands as Oticon, Bernafon, Sonic, Philips Hearing Solutions, Audika, MAICO, Interacoustics, Amplivox, Grason-Stadler, MedRx and Audioscan. William Demant Foundation holds the majority of shares in Demant A/S, which is listed on Nasdaq Copenhagen and among the 25 most traded stocks.
If you want to know how we process your personal data on social media platforms, visit this site: https://www.demant.com/privacy-notice#some